Literature DB >> 26472223

Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.

Xiaoying Liu1, Anne S Henkel2, Brian E LeCuyer2, Matthew J Schipma3, Kristy A Anderson2, Richard M Green2.   

Abstract

Fatty liver is associated with endoplasmic reticulum stress and activation of the hepatic unfolded protein response (UPR). Reduced hepatic expression of the UPR regulator X-box binding protein 1 spliced (XBP1s) is associated with human nonalcoholic steatohepatitis (NASH), and feeding mice a high-fat diet with fructose/sucrose causes progressive, fibrosing steatohepatitis. This study examines the role of XBP1 in nonalcoholic fatty liver injury and fatty acid-induced cell injury. Hepatocyte-specific Xbp1-deficient (Xbp1(-/-)) mice were fed a high-fat/sugar (HFS) diet for up to 16 wk. HFS-fed Xbp1(-/-) mice exhibited higher serum alanine aminotransferase levels compared with Xbp1(fl/fl) controls. RNA sequencing and Gene Ontogeny pathway analysis of hepatic mRNA revealed that apoptotic process, inflammatory response, and extracellular matrix structural constituent pathways had enhanced activation in HFS-fed Xbp1(-/-) mice. Liver histology demonstrated enhanced injury and fibrosis but less steatosis in the HFS-fed Xbp1(-/-) mice. Hepatic Col1a1 and Tgfβ1 gene expression, as well as Chop and phosphorylated JNK (p-JNK), were increased in Xbp1(-/-) compared with Xbp1(fl/fl) mice after HFS feeding. In vitro, stable XBP1-knockdown Huh7 cells (Huh7-KD) and scramble control cells (Huh7-SCR) were generated and treated with palmitic acid (PA) for 24 h. PA-treated Huh7-KD cells had increased cytotoxicity measured by lactate dehydrogenase release, apoptotic nuclei, and caspase3/7 activity assays compared with Huh7-SCR cells. CHOP and p-JNK expression was also increased in Huh7-KD cells following PA treatment. In conclusion, loss of XBP1 enhances injury in both in vivo and in vitro models of fatty liver injury. We speculate that hepatic XBP1 plays an important protective role in pathogenesis of NASH.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  endoplasmic reticulum stress; fatty liver; nonalcoholic steatohepatitis; steatosis; unfolded protein response

Mesh:

Substances:

Year:  2015        PMID: 26472223      PMCID: PMC4683298          DOI: 10.1152/ajpgi.00132.2015

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  39 in total

1.  Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.

Authors:  Jody Dushay; Patricia C Chui; Gosala S Gopalakrishnan; Marta Varela-Rey; Meghan Crawley; Ffolliott M Fisher; Michael K Badman; Maria L Martinez-Chantar; Eleftheria Maratos-Flier
Journal:  Gastroenterology       Date:  2010-05-05       Impact factor: 22.682

2.  PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.

Authors:  Elizabeth K Speliotes; Johannah L Butler; Cameron D Palmer; Benjamin F Voight; Joel N Hirschhorn
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

3.  Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease.

Authors:  I R Willner; B Waters; S R Patil; A Reuben; J Morelli; C A Riely
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

4.  Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver.

Authors:  Axel Behrens; Maria Sibilia; Jean-Pierre David; Uta Möhle-Steinlein; François Tronche; Günther Schütz; Erwin F Wagner
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

5.  IRE1α-XBP1s induces PDI expression to increase MTP activity for hepatic VLDL assembly and lipid homeostasis.

Authors:  Shiyu Wang; Zhouji Chen; Vivian Lam; Jaeseok Han; Justin Hassler; Brian N Finck; Nicholas O Davidson; Randal J Kaufman
Journal:  Cell Metab       Date:  2012-10-03       Impact factor: 27.287

6.  Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Mariana Lazo; Ruben Hernaez; Mark S Eberhardt; Susanne Bonekamp; Ihab Kamel; Eliseo Guallar; Ayman Koteish; Frederick L Brancati; Jeanne M Clark
Journal:  Am J Epidemiol       Date:  2013-05-23       Impact factor: 4.897

7.  Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.

Authors:  Ffolliott M Fisher; Patricia C Chui; Imad A Nasser; Yury Popov; Jeremy C Cunniff; Thomas Lundasen; Alexei Kharitonenkov; Detlef Schuppan; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  Gastroenterology       Date:  2014-07-30       Impact factor: 22.682

8.  Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent.

Authors:  Laura H Tetri; Metin Basaranoglu; Elizabeth M Brunt; Lisa M Yerian; Brent A Neuschwander-Tetri
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-09-04       Impact factor: 4.052

9.  GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information.

Authors:  Ruben Nogales-Cadenas; Pedro Carmona-Saez; Miguel Vazquez; Cesar Vicente; Xiaoyuan Yang; Francisco Tirado; Jose María Carazo; Alberto Pascual-Montano
Journal:  Nucleic Acids Res       Date:  2009-05-22       Impact factor: 16.971

Review 10.  In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD).

Authors:  Giridhar Kanuri; Ina Bergheim
Journal:  Int J Mol Sci       Date:  2013-06-05       Impact factor: 5.923

View more
  22 in total

1.  3D-printed gelatin scaffolds of differing pore geometry modulate hepatocyte function and gene expression.

Authors:  Phillip L Lewis; Richard M Green; Ramille N Shah
Journal:  Acta Biomater       Date:  2018-01-06       Impact factor: 8.947

Review 2.  Liver function and dysfunction - a unique window into the physiological reach of ER stress and the unfolded protein response.

Authors:  D Thomas Rutkowski
Journal:  FEBS J       Date:  2018-02-07       Impact factor: 5.542

3.  Interaction between stress responses and circadian metabolism in metabolic disease.

Authors:  Zhao Yang; Hyunbae Kim; Arushana Ali; Ze Zheng; Kezhong Zhang
Journal:  Liver Res       Date:  2017-09

Review 4.  Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease.

Authors:  Frank T Spradley; Jillian A Smith; Barbara T Alexander; Christopher D Anderson
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-03-06       Impact factor: 4.310

5.  Hepatic deletion of X-box binding protein 1 impairs bile acid metabolism in mice.

Authors:  Xiaoying Liu; Anne S Henkel; Brian E LeCuyer; Susan C Hubchak; Matthew J Schipma; Eric Zhang; Richard M Green
Journal:  J Lipid Res       Date:  2016-12-30       Impact factor: 5.922

6.  Loss of hepatocyte β-catenin protects mice from experimental porphyria-associated liver injury.

Authors:  Harvinder Saggi; Dhiman Maitra; An Jiang; Rong Zhang; Pengcheng Wang; Pamela Cornuet; Sucha Singh; Joseph Locker; Xiaochao Ma; Harry Dailey; Marc Abrams; M Bishr Omary; Satdarshan P Monga; Kari Nejak-Bowen
Journal:  J Hepatol       Date:  2018-10-01       Impact factor: 25.083

7.  Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice.

Authors:  Xiaoying Liu; Grace L Guo; Bo Kong; David B Hilburn; Susan C Hubchak; Seong Park; Brian LeCuyer; Antony Hsieh; Li Wang; Deyu Fang; Richard M Green
Journal:  Hepatology       Date:  2018-05-10       Impact factor: 17.425

8.  IRE1α prevents hepatic steatosis by processing and promoting the degradation of select microRNAs.

Authors:  Jie-Mei Wang; Yining Qiu; Zhao Yang; Hyunbae Kim; Qingwen Qian; Qinghua Sun; Chunbin Zhang; Lei Yin; Deyu Fang; Sung Hong Back; Randal J Kaufman; Ling Yang; Kezhong Zhang
Journal:  Sci Signal       Date:  2018-05-15       Impact factor: 8.192

Review 9.  Emerging roles for the ER stress sensor IRE1α in metabolic regulation and disease.

Authors:  Shijia Huang; Yuying Xing; Yong Liu
Journal:  J Biol Chem       Date:  2019-10-30       Impact factor: 5.157

10.  Hepatic E4BP4 induction promotes lipid accumulation by suppressing AMPK signaling in response to chemical or diet-induced ER stress.

Authors:  Meichan Yang; Deqiang Zhang; Zifeng Zhao; Julian Sit; Mischael Saint-Sume; Omar Shabandri; Kezhong Zhang; Lei Yin; Xin Tong
Journal:  FASEB J       Date:  2020-08-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.